DK1146859T3 - Fremgangsmåde til fremstilling af partikler til agglomeration - Google Patents

Fremgangsmåde til fremstilling af partikler til agglomeration

Info

Publication number
DK1146859T3
DK1146859T3 DK00913218T DK00913218T DK1146859T3 DK 1146859 T3 DK1146859 T3 DK 1146859T3 DK 00913218 T DK00913218 T DK 00913218T DK 00913218 T DK00913218 T DK 00913218T DK 1146859 T3 DK1146859 T3 DK 1146859T3
Authority
DK
Denmark
Prior art keywords
agglomeration
preparing particles
preparing
particles
Prior art date
Application number
DK00913218T
Other languages
English (en)
Inventor
Tsong-Toh Yang
Charles G Eckhart
Stephen K C Yu
Michael B Mitchell
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1146859T3 publication Critical patent/DK1146859T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Silicon Compounds (AREA)
DK00913218T 1999-01-28 2000-01-27 Fremgangsmåde til fremstilling af partikler til agglomeration DK1146859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23948699A 1999-01-28 1999-01-28
PCT/US2000/000496 WO2000044352A1 (en) 1999-01-28 2000-01-27 Method of preparing particles for agglomeration

Publications (1)

Publication Number Publication Date
DK1146859T3 true DK1146859T3 (da) 2005-12-19

Family

ID=22902364

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00913218T DK1146859T3 (da) 1999-01-28 2000-01-27 Fremgangsmåde til fremstilling af partikler til agglomeration

Country Status (12)

Country Link
EP (2) EP1516614A1 (da)
JP (2) JP3946445B2 (da)
CN (2) CN100467014C (da)
AR (1) AR022695A1 (da)
AT (1) ATE302596T1 (da)
AU (1) AU3470000A (da)
CA (1) CA2360649C (da)
DE (1) DE60022163T2 (da)
DK (1) DK1146859T3 (da)
ES (1) ES2248057T3 (da)
WO (1) WO2000044352A1 (da)
ZA (1) ZA200104005B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
AU2003217950A1 (en) * 2002-03-05 2003-09-22 Cleveland State University Agglomerated particles for aerosol drug delivery
CA2540005A1 (en) * 2003-09-26 2005-04-07 Schering Corporation Pulmonary disease treatment
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
BRPI0606364A2 (pt) 2005-02-10 2010-03-23 Glaxo Group Ltd processo para formar lactose adequada para uso em uma formulaÇço farmacÊutica
WO2026027448A1 (en) * 2024-07-29 2026-02-05 Inke, S.A. Micronization process of indacaterol acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP1393721B1 (en) * 1997-03-20 2008-11-26 Schering Corporation Dosage form of powder agglomerates
GB9808470D0 (en) * 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus

Also Published As

Publication number Publication date
HK1037137A1 (en) 2002-02-01
CN1341013A (zh) 2002-03-20
JP3946445B2 (ja) 2007-07-18
CN101480376B (zh) 2013-01-16
AR022695A1 (es) 2002-09-04
EP1146859B1 (en) 2005-08-24
AU3470000A (en) 2000-08-18
CA2360649A1 (en) 2000-08-03
CN101480376A (zh) 2009-07-15
DE60022163T2 (de) 2006-04-13
CA2360649C (en) 2005-09-20
ES2248057T3 (es) 2006-03-16
JP2002535352A (ja) 2002-10-22
EP1516614A1 (en) 2005-03-23
JP2006257103A (ja) 2006-09-28
ZA200104005B (en) 2002-08-16
ATE302596T1 (de) 2005-09-15
DE60022163D1 (de) 2005-09-29
WO2000044352A1 (en) 2000-08-03
CN100467014C (zh) 2009-03-11
EP1146859A1 (en) 2001-10-24

Similar Documents

Publication Publication Date Title
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
NO20014835L (no) Fremgangsmate for fremstilling av monodisperse polymerpartikler
FI991051A7 (fi) Huokosia sisältävien polymeerihiukkasten valmistamismenetelmä
DK1200231T3 (da) Fremgangsmåde til fremstilling af mikroslibeværktøjer
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK1051194T3 (da) Fremgangsmåde til fremstilling af absorberbare mikropartikler
DK1123103T3 (da) Fremgangsmåde til fremstilling af en jerndextranforbindelse
ID30091A (id) Metode untuk menyiapkan l-fenilefrina hidroklorida
DK1199927T3 (da) Fremgangsmåde til fremstilling af ammoniumglyphosatpulver
FI20001612A0 (fi) Menetelmä kuitulevyjen valmistamiseksi
DK0985733T3 (da) Fremgangsmåde til fremstilling af cyclodextrin
DK1210318T3 (da) Fremgangsmåde til fremstilling af adrenalin
DK1165503T3 (da) Fremgangsmåde til fremstilling af hydroxymethylthiosmörsyreesthere
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1232328T3 (da) Fremgangsmåde til indvinding af vandopløselige overfladeaktive midler
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
AU2002257890A1 (en) Method for replicating the hepatitis C virus
DK1240173T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin
DK1165483T3 (da) Fremgangsmåde til fremstilling af carbonylfluorid
DE60022163D1 (de) Verfahren zur herstellung von zur agglomeration geeigneten partikeln
SK284438B8 (sk) Spôsob prípravy n-fenyl-benzochinónimínu z hydroxydifenylamínov
DK1088817T3 (da) Fremgangsmåde til fremstilling af 3-acyl-indoler
NO308613B1 (no) FremgangsmÕte for fremstilling av granulatformig støpeasfalt
ID30126A (id) METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly)
DK1212095T3 (da) Fremgangsmåde til fremstilling af en formulering med opretholdt frigivelse